Literature DB >> 7486761

Current UK opinion on thromboprophylaxis in orthopaedic surgery: its use in routine total hip and knee arthroplasty.

A J Unwin1, J R Jones, W J Harries.   

Abstract

We surveyed all surgically qualified members of the British Orthopaedic Association as to their views on thromboprophylaxis in routine total hip and knee replacement. The response rate was 92%. In total hip replacement, 13-15% of surgeons used no method of prophylaxis at all, 18-22% did not use a mechanical method of prophylaxis, while 26% did not use a pharamacological agent; 36% believed low-dose anticoagulant thromboprophylaxis to be a medicolegal necessity while 47% disagreed with this. In total knee replacement, 18-33% of surgeons used no method of prophylaxis at all, 20-26% did not use a mechanical method of prophylaxis, while 54-58% did not use a pharmacological agent; 12 believed low-dose anticoagulant thromboprophylaxis to be a medicolegal necessity, while 64% disagreed with this. We conclude that mechanical methods remain a popular method of thromboprophylaxis and pharmacological methods, while commonly used, are not seen as a medicolegal requirement in lower limb arthroplasty and are used less often in total knee replacement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7486761      PMCID: PMC2502416     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  8 in total

1.  The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study.

Authors:  P S Jørgensen; J B Knudsen; L Broeng; L Josephsen; P Bjerregaard; K Hagen; P K Jørgensen; C Tørholm
Journal:  Clin Orthop Relat Res       Date:  1992-05       Impact factor: 4.176

2.  Total hip replacement and antithrombotic prophylaxis.

Authors:  I J Brenkel; M J Clancy
Journal:  Br J Hosp Med       Date:  1989-10

3.  Major orthopaedic surgery on the leg and thromboembolism.

Authors:  J Parker-Williams; R Vickers
Journal:  BMJ       Date:  1991-09-07

4.  Orthopaedic surgeons and thromboprophylaxis.

Authors:  M D Laverick; S A Croal; R A Mollan
Journal:  BMJ       Date:  1991-09-07

5.  Venous thromboembolism and orthopaedic surgery.

Authors:  M A McNally; R A Mollan
Journal:  J Bone Joint Surg Br       Date:  1993-07

6.  Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo.

Authors:  M R Lassen; L C Borris; H M Christiansen; K L Boll; S P Eiskjaer; B W Nielsen; P Schøtt; A D Olsen; J C Rodenberg; U Lucht
Journal:  Acta Orthop Scand       Date:  1991-02

7.  Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality.

Authors:  V Seagroatt; H S Tan; M Goldacre; C Bulstrode; I Nugent; L Gill
Journal:  BMJ       Date:  1991-12-07

8.  The use of thromboprophylaxis in total hip replacement surgery: are the attitudes of orthopaedic surgeons changing?

Authors:  T D Owen; J Coorsh
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000

  8 in total
  2 in total

1.  Current practice in primary total hip replacement: results from the National Hip Replacement Outcome Project.

Authors:  A J Best; D Fender; W M Harper; A W McCaskie; K Oliver; P J Gregg
Journal:  Ann R Coll Surg Engl       Date:  1998-09       Impact factor: 1.891

Review 2.  Economics of thromboprophylaxis in total hip replacement surgery.

Authors:  J Harrison; D J Warwick; J Coast
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.